The benefit of stents outweigh the risks. That's the word Thursday from an FDA commissioned panel after reviewing studies on stents, which are the tiny mesh tubes that prop open narrow arteries.
Over 5 million people worldwide have a stent implanted and for the past few years, the stent used most often is coated with drugs that prevent the build-up of scar tissue in the artery. But recently, studies pointed to an increased risk of blood clots in patients given the drug coated stents.
Thursday's decision brings some relief to those patients stating that the drug-coated stents provide far more good than risk.